|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
50937728
線上人數 :
986
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"tien feng ming"的相關文件
顯示項目 26-35 / 40 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-07-21T07:23:25Z |
Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies
|
Chen C.-Y.; Cheng A.; TIEN FENG-MING; Lee P.-C.; Tien H.-F.; Sheng W.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-07-21T07:23:25Z |
Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan
|
TIEN FENG-MING; Tsai C.-H.; Liu J.-H.; Lin C.-T. |
| 臺大學術典藏 |
2021-07-21T07:23:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; TIEN FENG-MING; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:24Z |
Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008�V2013
|
Chen C.-Y.; Sheng W.-H.; TIEN FENG-MING; Lee P.-C.; Huang S.-Y.; Tang J.-L.; Tsay W.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-07-21T07:23:23Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; TIEN FENG-MING; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-21T07:23:23Z |
Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
|
Wang Y.-H.; TIEN FENG-MING; Tsai C.-H.; Huang H.-H.; Liu J.-H.; Liao X.-W.; Tang J.-L.; Yao M.; Ko B.-S. |
| 臺大學術典藏 |
2021-07-21T07:23:23Z |
Feasibility, process, and effects of short-term calorie reduction in cancer patients receiving chemotherapy: An integrative review
|
Tang C.-C.; Chen H.; Huang T.-C.; Wu W.-W.; Lin J.-M.; TIEN FENG-MING |
| 臺大學術典藏 |
2021-07-21T07:23:22Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; TIEN FENG-MING; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-07-15T05:31:46Z |
Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
|
Wang, Yu Hung; Tien, Feng Ming; CHENG-HONG TSAI; Huang, Huai Hsuan; Liu, Jia Hau; Liao, Xiu Wen; JIH-LUH TANG; MING YAO; BOR-SHENG KO |
| 臺大學術典藏 |
2021-07-15T05:31:45Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
顯示項目 26-35 / 40 (共4頁)
<< < 1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
